Bicycle Therapeutics (BCYC) Long-Term Debt Issuances (2021)
Bicycle Therapeutics (BCYC) posted Long-Term Debt Issuances of $15.0 million for Q1 2021.
Bicycle Therapeutics (BCYC) Long-Term Debt Issuances (2021) Analysis & Trends
Bicycle Therapeutics' Long-Term Debt Issuances history runs 1 years deep, the most recent figure standing at $15.0 million for Q1 2021.
- Quarterly Long-Term Debt Issuances changed N/A year-over-year to $15.0 million in Q1 2021, while the trailing twelve-month figure through Dec 2021 was $15.0 million (changed N/A YoY) and the FY2021 annual result came in at $15.0 million, changed 0.0% from the prior year.
- Long-Term Debt Issuances was $15.0 million for Q1 2021 at Bicycle Therapeutics.
- Across five years, Long-Term Debt Issuances topped out at $15.0 million in Q1 2021 and bottomed at $15.0 million in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 15.00 Mn |
| Mar 31, 2021 | 15.00 Mn |